KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Cvs Health (CVS) EBIAT (2016 - 2025)

Cvs Health (CVS) has disclosed EBIAT for 17 consecutive years, with $2.9 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBIAT rose 80.1% year-over-year to $2.9 billion, compared with a TTM value of $1.7 billion through Dec 2025, down 62.32%, and an annual FY2025 reading of $1.8 billion, down 61.68% over the prior year.
  • EBIAT was $2.9 billion for Q4 2025 at Cvs Health, up from -$4.0 billion in the prior quarter.
  • Across five years, EBIAT topped out at $3.0 billion in Q2 2022 and bottomed at -$4.0 billion in Q3 2025.
  • Average EBIAT over 5 years is $1.3 billion, with a median of $1.8 billion recorded in 2023.
  • The sharpest move saw EBIAT soared 163.86% in 2023, then tumbled 5719.72% in 2025.
  • Year by year, EBIAT stood at $1.4 billion in 2021, then skyrocketed by 78.8% to $2.5 billion in 2022, then fell by 18.43% to $2.0 billion in 2023, then dropped by 19.77% to $1.6 billion in 2024, then soared by 80.1% to $2.9 billion in 2025.
  • Business Quant data shows EBIAT for CVS at $2.9 billion in Q4 2025, -$4.0 billion in Q3 2025, and $1.0 billion in Q2 2025.